cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Embecta Corp
2 own
2 watching
Current Price
$28.66
$0.16
(0.56%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,635.21M
52-Week High
52-Week High
49
52-Week Low
52-Week Low
22.3
Average Volume
Average Volume
0.4M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1,635.21M
icon52-Week High49
icon52-Week Low22.3
iconAverage Volume0.4M
iconDividend Yield--
iconP/E Ratio--
What does the Embecta Corp do?
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.
Read More
News & Events about Embecta Corp.
PR Newswire
2days ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Embecta Corp. - EMBC SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Embecta Corp. - EMBC PR Newswire NEW YORK, Feb. 6, 2023 NEW YORK, Feb. 6, 2023 /PRNewswire/ -- Pomerantz LLP...
PR Newswire
20days ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Embecta Corp. - EMBC SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Embecta Corp. - EMBC PR Newswire NEW YORK, Jan. 19, 2023 NEW YORK, Jan. 19, 2023 /PRNewswire/ -- Pomerantz LLP...
PR Newswire
28days ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Embecta Corp. - EMBC SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Embecta Corp. - EMBC PR Newswire NEW YORK, Jan. 12, 2023 NEW YORK, Jan. 12, 2023 /PRNewswire/ --Pomerantz LLP...
Business Wire
1month ago
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Embecta Corp. (Embecta or the Company) (NASDAQ: EMBC) on behalf of Embecta stockholders. Our investigation concerns whether Embecta has violated the federal securities...
Business Wire
1month ago
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Embecta Corp. (Embecta or the Company) (NASDAQ: EMBC) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or...
Frequently Asked Questions
Frequently Asked Questions
What is Embecta Corp share price today?
plus_minus_icon
Can Indians buy Embecta Corp shares?
plus_minus_icon
How can I buy Embecta Corp shares from India?
plus_minus_icon
Can Fractional shares of Embecta Corp be purchased?
plus_minus_icon
What are the documents required to start investing in Embecta Corp stocks?
plus_minus_icon
What is today’s traded volume of Embecta Corp?
plus_minus_icon
What is today’s market capitalisation of Embecta Corp?
plus_minus_icon
What is the 52-Week High and Low Range of Embecta Corp?
plus_minus_icon
What percentage is Embecta Corp down from its 52-Week High?
plus_minus_icon
What percentage is Embecta Corp up from its 52-Week Low?
plus_minus_icon
Current Price
$28.66
$0.16
(0.56%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00